Piper Sandler raises target for Cigna Group stock from USD 346.00 to USD 370.00

Published on 10/16/2026 at 10:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Investor Day kept 10-14 percent adjusted earnings per share growth through 2030. Cigna Group stock costs EUR 266.30 on October 16, 2026, 0.80 percent below Xetra close.

Targets and operating scale

On October 2, 2026, Piper Sandler raised its Cigna target from USD 346.00 to USD 370.00.
The September 30, 2026 Investor Day retained a 10-14 percent adjusted earnings per share growth target through 2030.
Cigna Group stock traded at EUR 266.30 at 10:15 a.m. CEST on October 16, 2026, 0.80 percent below the October 15, 2026 Xetra close of EUR 268.45.
Second-quarter 2026 revenue reached USD 71.7 billion, while adjusted earnings per share came to USD 7.78.

Extreme Nahaufnahme eines Stethoskop-Bruststücks auf einem medizinischen Formular mit Bokeh-Hintergrund — Cigna Group Makroaufnahme eines Stethoskops auf medizinischem Formular, ISIN US1255231003, Chrome-Metalloberfläche mit Bokeh-Hintergrund, Illustration mit AI erstellt.

Cigna Group (ISIN US1255231003) was trading at EUR 266.30 at Lang & Schwarz on October 16, 2026 at 10:15 a.m. CEST, down 0.80 percent versus the Xetra close of October 15, 2026 (EUR 268.45). On October 2, 2026, Piper Sandler raised its target for Cigna from USD 346.00 to USD 370.00 while maintaining an Overweight rating, as Markets Insider reported.

What does the target raise mean?

The higher target followed Cigna's Investor Day strategy update. PR Newswire reported on September 30, 2026 that the company introduced its Lead to One strategy, reaffirmed 2026 adjusted revenue of approximately USD 280 billion and set a 10-14 percent long-term adjusted earnings per share growth target through 2030.

For investors, the key tension is between that growth framework and execution in pharmacy benefit services. The Investor Day release also announced a USD 3.00 billion multi-year modernization and productivity initiative, giving the strategy a concrete capital-allocation component.

Three dated Cigna milestones

On July 30, 2026, Cigna reported second-quarter revenue of USD 71.7 billion and adjusted earnings per share of USD 7.78, according to the Yahoo Finance transcript. On September 30, 2026, the company set its 2030 growth framework at 10-14 percent adjusted earnings per share growth and announced the USD 3.00 billion initiative, per PR Newswire. On October 2, 2026, Piper Sandler lifted its target to USD 370.00 from USD 346.00, according to Investing.com.

Upcoming reporting dates

Cigna's third-quarter 2026 results are scheduled for November 5, 2026, according to PR Newswire. Barron's lists fiscal 2026 results for February 4, 2027, providing the next annual reporting marker.

Stock price and valuation context

Cigna's primary listing is on the NYSE, where the stock was last quoted at USD 298.81 on October 15, 2026 at 4:00 p.m. ET. The market capitalization was USD 79.0 billion, and the 52-week range was USD 208.40 to USD 311.34 as of October 16, 2026. The euro quotation remained below the October 15 Xetra close in the morning session.

The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.